AI-Assisted Rehabilitation In Frailty

NCT07176520 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2025-09-16

No results posted yet for this study

Summary

This study investigates the effectiveness and implementation of an AI-assisted rehabilitation tool for adults with frailty in the real-world. The main questions it aims to answer are:

Does AI-assisted rehabilitation among frail adults improve patients' physical outcomes? Is there a particular subgroup of frail subjects that will benefit most from AI-assisted rehabilitation?

Researchers will compare AI-assisted rehabilitation to standard practice (advice and QR link for rehabilitation videos to be done at home) to see if AI-assisted rehabilitation improves clinical outcomes compared to standard practice.

Participants will either:

Undergo an AI-assisted rehab with the AI-sensor tool or a standard practice post-discharge from community hospitals for 12 weeks.

Undergo interval assessments of outcomes. Keep a diary of outpatient rehabilitations (if applicable for the subjects).

Conditions

  • Frail

Interventions

DEVICE

AI-assisted rehabilitation

Receives AI-assisted rehabilitation post-discharge at home in addition to usual care

OTHER

usual care only

Verbal and written discharge summary, advice, and referral to outpatient physiotherapy (if applicable)

Sponsors & Collaborators

  • Jurong Community Hospital, Singapore

    collaborator UNKNOWN
  • SingHealth Community Hospitals

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2027-01-31
Completion
2027-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07176520 on ClinicalTrials.gov